SCHD vs. VIG: Which Dividend ETF Has the Edge in 2026?
The Schwab U.S. Dividend Equity ETF (SCHD) and the Vanguard Dividend Appreciation ETF (VIG) are two popular dividend ETFs, but they are built for d...
Amgen Inc (AMGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 1,589,554 | $575,609,596 | +1% | 0.17% |
| 2. | D E Shaw D. E. Shaw | 1,290,217 | $467,213,380 | +625% | 0.22% |
| 3. | 918,100 | $332,462,372 | +24% | 0.04% | |
| 4. | 847,300 | $306,824,276 | +38% | 0.04% | |
| 5. | Citadel Investment Group Ken Griffin | 703,984 | $254,926,687 | +281% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.50 | 10 | $1,655.00 | 3,582 | 2015-08-19 | Filing | |
| $166.64 | 3,000 | $499,907.10 | 3,572 | 2015-08-19 | Filing | |
| $152.29 | 1,500 | $228,435.00 | 2,000 | 2015-02-05 | Filing | |
| $152.29 | 1,500 | $228,435.00 | 2,000 | 2015-02-05 | Filing | |
| $111.77 | 894 | $99,919.25 | 185,013 | 2014-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $416.43 | 1,252 | $521,364.85 | 6,404 | 2026-08-13 | Filing | |
| $412.57 | 2,000 | $825,134.00 | 6,404 | 2026-08-11 | Filing | |
| $402.54 | 1,821 | $733,033.35 | 12,462 | 2026-08-06 | Filing | |
| $402.54 | 2,069 | $832,864.36 | 12,462 | 2026-08-06 | Filing | |
| $402.16 | 1,000 | $402,160.10 | 7,340 | 2026-08-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 49,362,016 | $17,874,973,549 | 0.27% | |
| 2. | 35,250,101 | $12,764,766,575 | 0.27% | |
| 3. | 30,560,537 | $11,066,581,658 | 0.33% | |
| 4. | 29,075,329 | $10,528,543,565 | 1.24% | |
| 5. | 16,320,446 | $5,909,959,888 | 0.47% |
News See All
Amgen (AMGN) Fell 5% on a Drug That Isn't Even Its Own. Here's the Lp(a) Bet Now in Question.
Amgen Inc. (NASDAQ:AMGN) shed roughly $12 billion in market value after hours on September 4, 2026. The stock declined by about 5% to $415.
Novartis' Failed Cholesterol Drug Trial Sends Ionis and Amgen Tumbling
Few concepts in cardiovascular medicine have sparked as much optimism as Lp(a)-lowering medications.
Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
During the September 8 episode of Mad Money, Jim Cramer said Amgen Inc.
Could AstraZeneca (AZN)’s Stronger Growth Make it a Better Bet than Amgen (AMGN)?
On August 27, AstraZeneca PLC (NYSE:AZN) and Amgen Inc. (NASDAQ:AMGN) scored a shared clinical victory.
Amgen (AMGN) Says Repatha Reduced Mortality Before a First Heart Attack or Stroke. Can Earlier Use Expand the Market?
Amgen Inc. (NASDAQ:AMGN) reported that Repatha reduced the risk of all-cause mortality by 20% in a prespecified secondary analysis of the Phase 3 VESALIUS-CV trial.
AstraZeneca Stock (AZN) Slides Despite New Esophagus Drug Trial Success
Shares in pharmaceuticals giant AstraZeneca ($AZN) and peer Amgen ($AMGN) both dropped in pre-market trading despite hailing successful trial resul...
The Week That Was, The Week Ahead: Macro and Markets, August 16
U.S. stocks ended another positive week near record highs, although Friday’s weak retail sales report took some of the shine off the rally. The S&P...
SCHD vs. VYMI vs. VIG: Which Is the Best Dividend ETF for Passive Income Investors?
A steady passive income stream means balancing current yield, dividend growth, and geographic exposure. Among the many dividend ETFs available, Sch...
Hedge Fund Resource Center